Safety issues in the treatment of patients with dorsalgia

P.R. Kamchatnov¹, A.V. Chugunov¹, Z.A. Ashalmagomedova², A.M. Shemshedinova²

¹Pirogov Russian National Research Medical University, Moscow

²Dagestan State Medical University, Makhachkala

Patient management with dorsalgia requires not only timely and reliable pain relief and rehabilitation measures but also compliance with the treatment safety. Unfortunately, the widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of such patients is associated with a certain risk of adverse events. The review examines the main complications during NSAIDs use from the gastrointestinal tract, cardiovascular and hepatobiliary system, etc., assesses the risks of adverse events in patients with comorbid pathology, analyzes their occurrence causes and ways to overcome them. When choosing a drug for the treatment of patients with an existing disease of these organs, you should choose those with minimal risk of complications and use short courses of treatment. The article provides information on flurbiprofen, which has a number of benefits that allow this drug to be widely used in the treatment of patients with dorsalgia.

Keywords: dorsalgia, pain syndrome, nonsteroidal anti-inflammatory drugs, treatment, adverse events.

For citation: Kamchatnov P.R., Chugunov A.V., Ashalmagomedova Z.A., Shemshedinova A.M. Safety issues in the treatment of patients with dorsalgia. RMJ. 2021;6:48–52 (in Russ.).